KOSPI · Healthcare · ₩122B
₩1,211-0.82%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 1.6% · as of 26.10.27
Among 97 제약 peers
Quarterly Revenue Growth
“이번 분기는 매출 회복이 실제 이익으로 이어지는 전환점이에요.”
In the company's words · 2026 2분기 filing